Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Technology Update

5 Jun 2007 15:00

ViaLogy PLC05 June 2007 ViaLogy Announces IPv6-capable MicroSPM(TM)for High Definition SurveillanceVideo Processing LONDON, June 5, 2007 -- ViaLogy plc (LSE: VIY), announced today that it hasdeveloped IPv6-capable MicroSPM(TM), compact embedded hardware for highdefinition video processing applications over IP-converged networks. MicroSPM(TM)extends ViaLogy's SPM(TM)software product family by delivering anetwork-centric hardware policy-engine for fully-autonomous incident-based rapiddetection, analysis and response. The MicroSPM(TM)platform addresses threemajor trends within the global surveillance industry: increasing adoption ofnetwork addressable digital video camera and thermal imagers; need for real-timeautonomous processing by moving the policy and the intelligence to the networkedge, and, the accelerated migration to IPv6 addressing standards. MicroSPM(TM)is powered by ViaLogy's proprietary, patented signal processingQuantum Resonance Interferometry ("QRI") technology for detecting weak signalsand image features in high background clutter. QRI delivers video-applicationsin the form of prepackaged user customizable policies in firmware. Initialapplications include: face-extraction in crowds; human, object and vehicledetection and counting, and license plate reading. Immediate verticals includedefense, oil & gas, enterprise safety and security, and, perimeter and bordersurveillance. MicroSPM(TM)enables high speed processing at the video source,only transmitting policy-based exceptions and events to the operator sites. Italso delivers plug-and-play interoperability for IP-enabled video and night-vision devices from different vendors. Today, video surveillance systems are an essential remote monitoring tool forcritical infrastructure, including airports, border crossings, ports, dams,trains and subways; financial and governmental institutions; power grids,utilities and refining facilities. Video is routinely used by businesses formonitoring entrances, walkways, parking lots and warehouses. In banks andretail, surveillance cameras are strategically positioned to monitor and recordthe behavior of customers and tellers. However, the bulk of decision making isperformed by human operators staring at multiple video consoles and manuallycontrolling cameras. Size of this overall video surveillance market is estimatedat over $3 billion for 2007, with sales of security cameras exceeding 6 millionunits and growing at over 30%. According to ViaLogy CTO, Dr. Sandeep Gulati, "Centralized operator-based videoviewing and security decision making is a major choke-point in timely response.Bulk of video is archived and only used for post-incident analysis. MicroSPM'real-time edge processing will significantly expand the actionable informationbandwidth for customers. This is consistent with our focus on broad marketapplications where ViaLogy's QRI signal processing becomes an enabler." ViaLogy President and CEO, Mr. Shah Talukder stated "Customers are facingsignificant challenges in managing a multitude of sensor, video and otherdevices in their networked environments. We see a significant opportunity forscaleable, cost effective and future-proof solutions to manage their global andregional security networks." He added, "We also see MicroSPM(TM)enablingpartners to IPv6-enable their fixed and mobile sensors and network subsystems". Vialogy is in discussions with customers and partners to pilot and deployMicroSPM(TM)within their surveillance infrastructure. For further information please contact: ViaLogyShah Talukder, President & CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Nov 201511:20 amRNSNotice of Results
12th Nov 20157:00 amRNSPositive independent study results for IONA test
28th Oct 20157:00 amRNSAppointment to the Board
15th Oct 20153:56 pmRNSWorld first: in-house antenatal reflex screening
14th Oct 20157:00 amRNSClinical laboratory with expanded capacity opened
14th Oct 20157:00 amRNSHolding(s) in Company
13th Oct 20154:08 pmRNSResult of AGM
13th Oct 20152:20 pmRNSHolding(s) in Company
13th Oct 20157:01 amRNSAGM Statement
13th Oct 20157:00 amRNSPremaitha collaborates with Wolfson screening lab
12th Oct 20157:00 amRNSIndependent study of the IONA® test published
2nd Oct 20157:00 amRNSPremaitha appoints Greek distributor
1st Oct 20154:14 pmRNSPatent Infringement Proceedings Update
22nd Sep 20157:00 amRNSFinal Results
22nd Sep 20157:00 amRNSPremaitha signs contract for IONA test in Chile
15th Jul 20157:00 amRNSGrant of Options
13th Jul 20152:04 pmRNSHolding(s) in Company
6th Jul 20157:00 amRNSCQC accreditation for new NIPT lab
2nd Jul 20152:59 pmRNSCompletion of placing to raise £8 million
2nd Jul 20157:00 amRNSProposed placing to raise approximately £8 million
24th Jun 20157:00 amRNSNew IONA test clinical data showcased
22nd Jun 20157:00 amRNSNew contract for IONA® test
19th Jun 20157:00 amRNSTrading Update
4th Jun 20157:00 amRNSAppointment of Chief Financial Officer
5th May 20157:01 amRNSPremaitha Files Robust Defence with UK High Court
29th Apr 20151:53 pmRNSReissue of Options
31st Mar 20157:00 amRNSNew Contract for IONA test in Poland
23rd Mar 20159:53 amRNSLondon NHS trust teams up with Premaitha Health
16th Mar 20159:40 amRNSNotice of Patent Infringement Proceedings
16th Mar 20157:00 amRNSPremaitha Health signs first NIPT agreement
5th Feb 20157:00 amRNSCE Mark and Launch of the IONA test
30th Jan 20157:00 amRNSCommercial Launch Preparation Update
10th Dec 20147:00 amRNSResults for 7 months to 30 September 2014
25th Nov 20147:00 amRNSNotice of Half Year Results and IONA Test Showcase
4th Nov 201412:07 pmRNSResult of AGM
4th Nov 20147:00 amRNSAGM Statement
2nd Oct 20147:00 amRNSGrant of Options
30th Sep 20147:00 amRNSPublication of Annual Report and Notice of AGM
7th Jul 20144:47 pmRNSHolding(s) in Company
4th Jul 20144:28 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSFirst Day of Dealings on AIM
3rd Jul 20143:42 pmRNSChange of Name
3rd Jul 201411:36 amRNSResult of EGM
1st Jul 201410:47 amRNSOpen Offer Oversubcribed
13th Jun 20147:30 amRNSRestoration - ViaLogy Plc
13th Jun 20147:30 amRNSSchedule 1 - ViaLogy Plc
13th Jun 20147:00 amRNSPublication of Admission Document & Lifting of...
13th Jun 20147:00 amRNSDirectorate Change
13th Jun 20147:00 amRNSFinal Results
15th Apr 201412:30 pmRNSSuspension - Vialogy plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.